摘要
肉瘤样/促纤维增生性间皮瘤与肺肉瘤样癌胸膜转移的鉴别诊断较为困难,两者形态学类似且常仅表达广谱细胞角蛋白。GATA结合蛋白3(GATA binding protein 3,GATA3)免疫组化标记主要表达在乳腺癌及尿路上皮癌, 但也可表达于其他类型肿瘤,如间皮瘤。本研究中,我们探究了GATA3免疫组化染色是否可用于鉴别肉瘤样/ 促纤维增生性间皮瘤(N=19)与肺肉瘤样癌(N=13)。免疫组化染色结果根据染色强度及范围进行评分,最高分值为6分。所有19例肉瘤样/促纤维增生性间皮瘤均为弥漫强阳性染色(无病例低于3分,19例平均值±标准差5.4±0.9),而13例肺肉瘤样癌中仅有2例GATA3染色阳性,且仅为灶状弱阳性(两例评分均为2分,13例平均值±标准差0.4±0.8)。此外,GATA3染色阳性强度及范围与传统间皮瘤标记间无明确相关性。综上,任何程度的GATA3阳性染色在肉瘤样/促纤维增生性间皮瘤中表达的敏感性为100%,特异性为85%。因此,我们认为,GATA3弥漫强阳性染色支持肉瘤样/促纤维增生性间皮瘤而非肺肉瘤样癌。反之,GATA3表达完全缺失则是不支持诊断为肉瘤样/ 促纤维增生性间皮瘤的有力依据。
来源:Am J Surg Pathol 2017;41:1221–1225
美国外科病理学杂志中文版2017年第一期摘要No.7
(李媛 翻译/审校)
The American Journal of Surgical Pathology中文版声明:
2017 American Journal of Surgical Pathology and Wolters Kluwer Health
The material is published by Wolters Kluwer Health with the permission of American Journal of Surgical Pathology.No
part of this publication may be reproduced in any form,stored in a retrieval system or transmitted in any form,by any means,without prior written permission from Wolters Kluwer Health.Opinions expressed by the authors and advertisers are not necessarily those of the American Journal of Surgical Pathology, its affiliates,or of the Publisher.The American Journal of Surgical Pathology,its affiliates,and the Publisher disclaim any liability to any party for the accuracy,completeness,efficacy,or availability of the material contained in this publication (including drug dosages) or for any damages arising out of the use or non-use of any of the material contained in this publication.
Although advertising material is expected to conform to ethical (medical) standards,inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.